PURPOSE: This study contrasted the effect of a group-mediated cognitive-behavioral intervention (GMCB) versus traditional cardiac rehabilitation (CRP) upon changes in objective and self-reported physical function of older adults [mean (SD) age of 64.7 (7.5) yr] after 3 months of exercise therapy. METHODS: This randomized clinical trial enrolled 147 participants who were eligible for inclusion into cardiac rehabilitation. Baseline to 3-month changes in self-reported and performance related measures of physical function were assessed using a physical functioning questionnaire, a 6-min walk test, and measured MET levels. RESULTS: Paired t-tests revealed that participants made improvements in all measures across the first 3 months of the study, irrespective of group treatment (P < 0.001). General linear models including effects for baseline levels of physical function, treatment, and gender revealed that lower functioning men in the GMCB treatment made greater improvements than any other subgroup on the two performance outcomes: 6-min walk and measured MET levels (P < 0.01). Gender did not moderate change in self-reported level of physical function (P > 0.05); however, the lower functioning participants in the GMCB intervention experienced greater improvements in self-reported physical function than those in CRP (P < 0.05). CONCLUSIONS:Exercise therapy is a valuable intervention for improving physical function of older adults with cardiovascular disease (CVD) and those at increased risk for CVD. Baseline level of physical function and gender are important variables to consider when studying the relationship between exercise therapy and improvements in physical function.
RCT Entities:
PURPOSE: This study contrasted the effect of a group-mediated cognitive-behavioral intervention (GMCB) versus traditional cardiac rehabilitation (CRP) upon changes in objective and self-reported physical function of older adults [mean (SD) age of 64.7 (7.5) yr] after 3 months of exercise therapy. METHODS: This randomized clinical trial enrolled 147 participants who were eligible for inclusion into cardiac rehabilitation. Baseline to 3-month changes in self-reported and performance related measures of physical function were assessed using a physical functioning questionnaire, a 6-min walk test, and measured MET levels. RESULTS: Paired t-tests revealed that participants made improvements in all measures across the first 3 months of the study, irrespective of group treatment (P < 0.001). General linear models including effects for baseline levels of physical function, treatment, and gender revealed that lower functioning men in the GMCB treatment made greater improvements than any other subgroup on the two performance outcomes: 6-min walk and measured MET levels (P < 0.01). Gender did not moderate change in self-reported level of physical function (P > 0.05); however, the lower functioning participants in the GMCB intervention experienced greater improvements in self-reported physical function than those in CRP (P < 0.05). CONCLUSIONS: Exercise therapy is a valuable intervention for improving physical function of older adults with cardiovascular disease (CVD) and those at increased risk for CVD. Baseline level of physical function and gender are important variables to consider when studying the relationship between exercise therapy and improvements in physical function.
Authors: Capri G Foy; Mara Z Vitolins; L Douglas Case; Susan J Harris; Carol Massa-Fanale; Richard J Hopley; Leah Gardner; Nicole Rudiger; Kathryn Yamamoto; Brittany Swain; David C Goff; Suzanne C Danhauer; Deborah Booth; Jamie Gaspari Journal: Contemp Clin Trials Date: 2013-07-19 Impact factor: 2.226
Authors: Shannon M Dunlay; Brandi J Witt; Thomas G Allison; Sharonne N Hayes; Susan A Weston; Ellen Koepsell; Véronique L Roger Journal: Am Heart J Date: 2009-09-29 Impact factor: 4.749
Authors: Luc J Martin; Shauna M Burke; Sheree Shapiro; Albert V Carron; Jennifer D Irwin; Robert Petrella; Harry Prapavessis; Kevin Shoemaker Journal: BMC Public Health Date: 2009-07-31 Impact factor: 3.295
Authors: W Jack Rejeski; Bonnie Spring; Kathryn Domanchuk; Huimin Tao; Lu Tian; Lihui Zhao; Mary M McDermott Journal: J Transl Med Date: 2014-01-28 Impact factor: 5.531